ARTICLE | Distillery Therapeutics
Repeat expansion-targeting antisense oligo for ALS and frontotemporal dementia
September 29, 2020 1:03 AM UTC
DISEASE CATEGORY: Neurology
INDICATION: Amyotrophic lateral sclerosis (ALS); frontotemporal dementia...
BCIQ Target Profiles